GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » Construction In Progress

Betta Pharmaceuticals Co (SZSE:300558) Construction In Progress : ¥180 Mil (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co Construction In Progress?

Betta Pharmaceuticals Co's quarterly construction in progress declined from Sep. 2024 (¥2,329 Mil) to Dec. 2024 (¥192 Mil) and declined from Dec. 2024 (¥192 Mil) to Mar. 2025 (¥180 Mil).

Betta Pharmaceuticals Co's annual construction in progress increased from Dec. 2022 (¥1,448 Mil) to Dec. 2023 (¥2,037 Mil) but then declined from Dec. 2023 (¥2,037 Mil) to Dec. 2024 (¥192 Mil).


Betta Pharmaceuticals Co Construction In Progress Historical Data

The historical data trend for Betta Pharmaceuticals Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Betta Pharmaceuticals Co Construction In Progress Chart

Betta Pharmaceuticals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63.12 639.67 1,447.89 2,036.59 191.87

Betta Pharmaceuticals Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,122.03 2,174.35 2,328.57 191.87 180.07

Betta Pharmaceuticals Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Betta Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 355, Xingzhong Road, Economic and Technological Development Zone, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311100
Betta Pharmaceuticals Co Ltd is a pharmaceutical enterprise that focuses on the research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates in China.
Executives
Wang Jia Bing Directors, executives
Ding Lie Ming Directors, executives
Cai Wan Yu Executives

Betta Pharmaceuticals Co Headlines

No Headlines